Aktiesnakken — Maj 2011
-
Så bliver Danisco da i hvert fald ikke afnoteret..
-
USA ser ikke lyst på det i dag..
-
Vestas skal have en fa analyse i nakken.
-
Genmab - named patient kan vi huske fra neurosearch. Hele spørgsmålet må gå på om de får udgifterne refunderet. Oplagt analytiker spørgsmål
-
Søg på neuro.
-
Sidder på iphone. Jeg lægger mærke til at der er et flueben ved named patients
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind